TW200508197A - Indolone-acetamide derivatives, processes for preparing them and their uses - Google Patents
Indolone-acetamide derivatives, processes for preparing them and their usesInfo
- Publication number
- TW200508197A TW200508197A TW093106822A TW93106822A TW200508197A TW 200508197 A TW200508197 A TW 200508197A TW 093106822 A TW093106822 A TW 093106822A TW 93106822 A TW93106822 A TW 93106822A TW 200508197 A TW200508197 A TW 200508197A
- Authority
- TW
- Taiwan
- Prior art keywords
- indolone
- preparing
- processes
- acetamide derivatives
- acetamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03007214 | 2003-03-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200508197A true TW200508197A (en) | 2005-03-01 |
Family
ID=33104041
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW093106822A TW200508197A (en) | 2003-03-31 | 2004-03-15 | Indolone-acetamide derivatives, processes for preparing them and their uses |
Country Status (19)
Country | Link |
---|---|
US (2) | US7645887B2 (zh) |
EP (1) | EP1620399B1 (zh) |
JP (1) | JP2006522041A (zh) |
KR (1) | KR20050119186A (zh) |
CN (1) | CN100364973C (zh) |
AR (1) | AR043959A1 (zh) |
AT (1) | ATE482193T1 (zh) |
AU (1) | AU2004226288A1 (zh) |
BR (1) | BRPI0408863A (zh) |
CA (1) | CA2520568A1 (zh) |
DE (1) | DE602004029245D1 (zh) |
ES (1) | ES2353461T3 (zh) |
HK (1) | HK1089768A1 (zh) |
MX (1) | MXPA05009089A (zh) |
NO (1) | NO20055026L (zh) |
RU (1) | RU2005131317A (zh) |
TW (1) | TW200508197A (zh) |
WO (1) | WO2004087658A1 (zh) |
ZA (1) | ZA200507231B (zh) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200508197A (en) | 2003-03-31 | 2005-03-01 | Ucb Sa | Indolone-acetamide derivatives, processes for preparing them and their uses |
AU2005214258A1 (en) * | 2004-02-23 | 2005-09-01 | Dainippon Sumitomo Pharma Co., Ltd. | Novel heterocyclic compound |
ATE482194T1 (de) | 2004-07-22 | 2010-10-15 | Ucb Pharma Sa | Indolonderivate, verfahren zu deren herstellung und deren anwendungen |
WO2006118265A1 (ja) | 2005-04-28 | 2006-11-09 | Eisai R & D Management Co., Ltd. | 抗痴呆薬を含有する組成物 |
EP2308870A3 (en) * | 2005-06-01 | 2011-10-19 | UCB Pharma S.A. | 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses |
US7790726B2 (en) * | 2005-08-16 | 2010-09-07 | Chemocentryx, Inc. | Monocyclic and bicyclic compounds and methods of use |
TW200801011A (en) | 2006-02-07 | 2008-01-01 | Astrazeneca Ab | New compounds II |
BRPI0710487A2 (pt) * | 2006-04-12 | 2012-06-05 | Merck & Co Inc | composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitácel do mesmo e, método para tratar ou controlar a epilepsia e a dor e para o tratamento ou prevenção de um distúrbio do sono em um paciente. |
WO2008133933A1 (en) * | 2007-04-26 | 2008-11-06 | Trustees Of Columbia University In The City Of New York | Methods, systems, and compositions for treating or ameliorating the effects of a non-congenital hypertonia |
WO2008132139A2 (en) * | 2007-04-27 | 2008-11-06 | Ucb Pharma S.A. | New heterocyclic derivatives useful for the treatment of cns disorders |
EP2212293A4 (en) * | 2007-10-24 | 2010-12-01 | Merck Sharp & Dohme | ANTAGONISTS OF T-TYPE CALCIUM CHANNELS BASED ON HETEROCYCLIC AMIDE |
BRPI0818244A2 (pt) * | 2007-10-24 | 2015-06-16 | Merck Sharp & Dohme | Composto, composição farmacêutica, uso de um composto, e, método para tratamento de um distúrbio ou doença |
CN102227217A (zh) | 2008-10-16 | 2011-10-26 | 约翰斯.霍普金斯大学 | 改善认知功能的方法和组合物 |
EA037187B1 (ru) | 2010-02-09 | 2021-02-17 | Дзе Джонс Хопкинс Юниверсити | Способ и композиция для лечения когнитивного расстройства |
US10154988B2 (en) | 2012-11-14 | 2018-12-18 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
WO2014144801A1 (en) | 2013-03-15 | 2014-09-18 | Agenebio Inc. | Methods and compositions for improving cognitive function |
WO2014144663A1 (en) | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
WO2015110435A1 (en) | 2014-01-21 | 2015-07-30 | Janssen Pharmaceutica Nv | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
LT3096790T (lt) | 2014-01-21 | 2019-10-10 | Janssen Pharmaceutica, N.V. | Deriniai, apimantys 2 potipio metabotropinio glutamaterginio receptoriaus teigiamus alosterinius moduliatorius arba ortosterinius agonistus, ir jų panaudojimas |
CN107540597A (zh) * | 2017-09-22 | 2018-01-05 | 苏州大学 | N‑乙酰二甲胺基吲哚‑2‑酮衍生物的制备方法 |
US20210214359A1 (en) * | 2018-05-29 | 2021-07-15 | New York University | Compounds and Methods for Treating Bacterial Infections |
KR102669101B1 (ko) * | 2021-08-10 | 2024-05-27 | 충북대학교 산학협력단 | 신규한 옥소인돌린 기반 아세토히드라지드 및 이를 유효성분으로 포함하는 항암제 조성물 |
CN114874127B (zh) * | 2022-05-23 | 2023-06-09 | 中国药科大学 | 一种二氟羰基化吲哚酮类化合物的制备方法 |
US20240132513A1 (en) | 2022-08-19 | 2024-04-25 | Agenebio, Inc. | Benzazepine derivatives, compositions, and methods for treating cognitive impairment |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3064910D1 (en) | 1979-06-12 | 1983-10-27 | Fujisawa Pharmaceutical Co | 2-oxo-benzothiazoline, benzoxazoline or indoline derivatives, their preparation, and pharmaceutical compositions comprising such derivatives |
JPS5697268A (en) * | 1979-12-28 | 1981-08-05 | Fujisawa Pharmaceut Co Ltd | Lower alkanoic acid derivative, salt and preparation thereof and preventing agent and remedy for diabetic complication containing the same as active constituent |
SU841264A1 (ru) * | 1980-02-20 | 1995-11-10 | Научно-исследовательский институт фармакологии АМН СССР | Амид-2-оксо-1-индолинуксусной кислоты, обладающий противосудорожной активностью |
DE3413572A1 (de) * | 1984-04-11 | 1985-10-24 | Hoechst Ag, 6230 Frankfurt | Oxindol-verbindungen zur behandlung der epilepsie |
GB8601160D0 (en) * | 1986-01-17 | 1986-02-19 | Fujisawa Pharmaceutical Co | Heterocyclic compounds |
DK288287A (da) * | 1986-06-09 | 1987-12-10 | Pfizer | Heterocycliske forbindelser samt farmaceutiske praeparater til behandling af allergiske eller inflammatoriske tilstande |
JPH0195766A (ja) | 1987-10-08 | 1989-04-13 | Tamanoisu Kk | 無蒸煮アルコール醪からの食酢の製造法 |
US5021576A (en) * | 1989-10-27 | 1991-06-04 | American Home Products Corporation | 2-Anilino phenylacetic acid derivatives |
CA2036307C (en) | 1990-03-08 | 2002-07-09 | Susan Jean Ward | 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions and method |
IE914003A1 (en) * | 1990-11-20 | 1992-05-20 | Astra Pharma Prod | Biologically Active Amines |
BR9200951A (pt) * | 1991-03-21 | 1992-11-17 | Hoffmann La Roche | Compostos, processo para sua producao,preparacoes farmaceuticas e uso |
US5322950A (en) * | 1991-12-05 | 1994-06-21 | Warner-Lambert Company | Imidazole with angiotensin II antagonist properties |
US5514690A (en) | 1992-11-17 | 1996-05-07 | E. R. Squibb & Sons, Inc. | Aminocarbonyl (thiocarbonyl) and cyanoguanidine derivatives of quinoline and indoline |
SE9302080D0 (sv) * | 1993-06-16 | 1993-06-16 | Ab Astra | New compounds |
JPH07304736A (ja) * | 1994-05-10 | 1995-11-21 | Kyowa Hakko Kogyo Co Ltd | インドール誘導体 |
US5565483A (en) * | 1995-06-07 | 1996-10-15 | Bristol-Myers Squibb Company | 3-substituted oxindole derivatives as potassium channel modulators |
FR2738818B1 (fr) * | 1995-09-18 | 1997-12-05 | Valentonine | Nouveaux derives d'oxydation d'indolylalkylamines, et leur utilisation a titre de medicament |
JP2002514162A (ja) * | 1996-07-08 | 2002-05-14 | デュポン ファーマシューティカルズ カンパニー | Xa因子阻害薬およびトロンビン阻害薬としてのアミジノインドール類、アミジノアゾール類、およびそれらの類似体 |
JPH1095766A (ja) * | 1996-09-19 | 1998-04-14 | Sanwa Kagaku Kenkyusho Co Ltd | アセトアミド誘導体、及びその用途 |
US7129250B2 (en) | 2000-05-19 | 2006-10-31 | Aegera Therapeutics Inc. | Neuroprotective and anti-proliferative compounds |
CA2308994A1 (en) | 2000-05-19 | 2001-11-19 | Aegera Therapeutics Inc. | Neuroprotective compounds |
AU2002213204A1 (en) * | 2000-10-13 | 2002-04-22 | Bristol-Myers Squibb Company | Selective maxi-K- potassium channel openers functional under conditions of high intracellular calcium concentration, methods and uses thereof |
AU2004222383B2 (en) * | 2003-03-14 | 2009-10-01 | Merck Sharp & Dohme Corp. | Bicyclic anilide spirohydantoin CGRP receptor antagonists |
TW200508197A (en) | 2003-03-31 | 2005-03-01 | Ucb Sa | Indolone-acetamide derivatives, processes for preparing them and their uses |
ATE482194T1 (de) | 2004-07-22 | 2010-10-15 | Ucb Pharma Sa | Indolonderivate, verfahren zu deren herstellung und deren anwendungen |
-
2004
- 2004-03-15 TW TW093106822A patent/TW200508197A/zh unknown
- 2004-03-16 RU RU2005131317/04A patent/RU2005131317A/ru not_active Application Discontinuation
- 2004-03-16 MX MXPA05009089A patent/MXPA05009089A/es not_active Application Discontinuation
- 2004-03-16 ES ES04720863T patent/ES2353461T3/es not_active Expired - Lifetime
- 2004-03-16 AT AT04720863T patent/ATE482193T1/de not_active IP Right Cessation
- 2004-03-16 EP EP04720863A patent/EP1620399B1/en not_active Expired - Lifetime
- 2004-03-16 US US10/550,667 patent/US7645887B2/en not_active Expired - Fee Related
- 2004-03-16 DE DE602004029245T patent/DE602004029245D1/de not_active Expired - Lifetime
- 2004-03-16 CN CNB2004800087283A patent/CN100364973C/zh not_active Expired - Fee Related
- 2004-03-16 CA CA002520568A patent/CA2520568A1/en not_active Abandoned
- 2004-03-16 BR BRPI0408863-8A patent/BRPI0408863A/pt not_active IP Right Cessation
- 2004-03-16 AU AU2004226288A patent/AU2004226288A1/en not_active Abandoned
- 2004-03-16 ZA ZA200507231A patent/ZA200507231B/en unknown
- 2004-03-16 JP JP2006504696A patent/JP2006522041A/ja active Pending
- 2004-03-16 WO PCT/EP2004/002691 patent/WO2004087658A1/en active Application Filing
- 2004-03-16 KR KR1020057018789A patent/KR20050119186A/ko not_active Application Discontinuation
- 2004-03-30 AR ARP040101049A patent/AR043959A1/es not_active Application Discontinuation
-
2005
- 2005-10-28 NO NO20055026A patent/NO20055026L/no not_active Application Discontinuation
-
2006
- 2006-09-15 HK HK06110230A patent/HK1089768A1/xx not_active IP Right Cessation
-
2009
- 2009-11-20 US US12/622,533 patent/US7964593B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2353461T3 (es) | 2011-03-02 |
US7964593B2 (en) | 2011-06-21 |
US7645887B2 (en) | 2010-01-12 |
KR20050119186A (ko) | 2005-12-20 |
AR043959A1 (es) | 2005-08-17 |
EP1620399B1 (en) | 2010-09-22 |
MXPA05009089A (es) | 2005-11-17 |
ATE482193T1 (de) | 2010-10-15 |
EP1620399A1 (en) | 2006-02-01 |
BRPI0408863A (pt) | 2006-04-11 |
NO20055026D0 (no) | 2005-10-28 |
US20100069375A1 (en) | 2010-03-18 |
JP2006522041A (ja) | 2006-09-28 |
AU2004226288A1 (en) | 2004-10-14 |
DE602004029245D1 (de) | 2010-11-04 |
CA2520568A1 (en) | 2004-10-14 |
CN1768036A (zh) | 2006-05-03 |
WO2004087658A1 (en) | 2004-10-14 |
US20070043038A1 (en) | 2007-02-22 |
ZA200507231B (en) | 2006-11-29 |
NO20055026L (no) | 2005-12-22 |
CN100364973C (zh) | 2008-01-30 |
HK1089768A1 (en) | 2006-12-08 |
RU2005131317A (ru) | 2006-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200508197A (en) | Indolone-acetamide derivatives, processes for preparing them and their uses | |
TW200716605A (en) | 2,6-quinolinyl derivatives, processes for preparing them and their uses | |
EP2308870A3 (en) | 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses | |
TWI268278B (en) | 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses | |
TW200611904A (en) | Aza-bicyclononanes | |
DE602004021472D1 (en) | Pyrimiidinverbindungen | |
TW200738659A (en) | Novel compounds | |
TW200508214A (en) | Novel compounds | |
TW200800999A (en) | Novel compounds | |
WO2007065595A3 (en) | Xanthine derivatives, processes for preparing them and their uses | |
TW200505875A (en) | Novel compounds | |
TW200612892A (en) | Novel compounds | |
TW200635921A (en) | Organic compounds | |
TW200800967A (en) | Benzimidazole thiophene compounds | |
GB0130341D0 (en) | Compounds | |
DE602004024213D1 (en) | Aminopropanolderivate | |
ZA200604410B (en) | Imidazole derivatives, processes for preparing them and their uses | |
PT1877367E (pt) | Derivados do acetileno | |
TW200510344A (en) | Aryl-heteroaromatic products, compositions comprising them and use | |
TW200501965A (en) | Highly pure fondaparinux sodium composition,process for preparing said composition and pharmaceutical compositions containing it as active principle | |
MXPA05008099A (es) | Productos n-aril-heteroaromaticos, composiciones que los contienen y su utilizacion. | |
MY134026A (en) | ?-carboline derivatives and its pharmaceutical use against depression and anxiety | |
MY149864A (en) | Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties | |
SE0300457D0 (sv) | Novel compounds | |
GB0615105D0 (en) | Novel compounds |